Posted October 19, 2020

Seller of Thrive "Anti-Viral" Supplements Settles with FTC for Unproven Coronavirus and Cancer Claims

On October 19, 2020, the Federal Trade Commission (FTC) approved an administrative consent order to settle charges that marketer Marc Ching was making unsubstantiated claims that the supplement Thrive can treat, prevent, or reduce the risk of coronavirus (COVID-19). Thrive consists mainly of vitamin C and herbal extracts.

As part of the settlement, Ching must send written notices to consumers and retailers of Thrive explaining that the product does not "treat, prevent, or reduce the risk of COVID-19" and that his CBD products do not treat cancer.

The FTC first filed a complaint against Ching and his company Whole Leaf Organics in April 2020. Ching had been selling Thrive online since December 2018 and began marketing the product as an "anti viral wellness booster" that treats coronavirus in March 2020. 

See ConsumerLab's answers to the question What are natural remedies for coronavirus (COVID-19)? Do supplements like zinc, vitamin C, or herbals work?

For more information, use the link below.

FTC Approves Final Administrative Consent Order with Marketer of Product Falsely Claiming to Prevent or Treat COVID-19

See Related Warnings:

Seller of Thrive "Anti-Viral" Supplement Barred from Making Unproven Coronavirus and Cancer Claims

Prairie Dawn Herbs Warned for COVID-19 Claims

Griffo Botanicals Warned for COVID-19 Claims

Tonic Therapeutic Herb Shop & Elixir Bar Warned for COVID-19 Claims

FDA Warns Consumers about Fraudulent Tests, Vaccines, and Treatments for COVID-19

FDA Warns Seller of Unapproved "COVID-19 test package"

FDA Warns Seller of Unapproved "Wondfo Novel Coronavirus Antibody Detection Kit"